StockVS

NASDAQ · Medical Instruments & Supplies · USD

Merit Medical Systems, Inc. (MMSI) Stock Analysis

Merit Medical Systems, Inc. (MMSI) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

MMSI

$89.60

+$1.03 (+1.16%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MMSI with… →

MMSI Key Statistics

As of Sep 4, 2026
Trading
Open
$87.68
Previous Close
$88.57
Day's Range
87.04–89.69
52-Week Range
59.74–94.75
Volume
599.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.49
Valuation
Market Cap
$5.35B
P/E Ratio
36.57
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
19.43
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.60
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.39
EPS (ttm)Profit attributable to each share over the last twelve months.
2.45
Financials (FY)
Revenue (FY)
$1.52B+11.75%
Net Income (FY)
$128.49M+6.76%
Profit marginThe share of revenue left as profit after all costs and taxes.
9.22%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
59.71M
1-Year Return
−2.77%
Dividend and dates
Earnings Date
October 29, 2026
Avg Volume
892.23K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MMSI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+1.66%
2025−8.87%
2024+27.33%
2023+7.56%
2022+13.35%
2021+12.23%
2020+77.80%
2019−44.06%
2018+29.19%
2017+63.02%
2016 (partial year)+14.92%

As of September 4, 2026.

MMSI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.52B$128.49M8.5%
2024$1.36B$120.36M8.9%
2023$1.26B$94.41M7.5%
2022$1.15B$74.52M6.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.52B$738.27M$185.70M$128.49M8.5%
2024$1.36B$643.33M$156.14M$120.36M8.9%
2023$1.26B$583.87M$127.47M$94.41M7.5%
2022$1.15B$519.10M$101.06M$74.52M6.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MMSI Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricMMSIMedical Instruments & Supplies medianvs median
P/E36.5735.613% above
P/S ratio3.393.177% above
Profit margin9.22%0.85%8.4 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 18 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Merit Medical Systems, Inc. (MMSI) at $5.35B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 7,500.

Over the past 52 weeks the price has ranged from $59.74 to $94.75. MMSI last closed at $89.60 on September 4, 2026. That is +$1.03 (+1.16%) against the previous close. The latest close sits 49.98% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.52B. That is +11.75% against the prior fiscal year, when revenue was $1.36B. The same year closed with net income of $128.49M. That is +6.76% against the prior fiscal year. Profit margin runs at 9.22%. That is 8.4 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 2.45.

Across the 4 fiscal years on file, revenue moves from $1.15B in 2022 to $1.52B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 36.57 times earnings. That is 2.68% above the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 19.43. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.6. The price-to-sales ratio is 3.39. On price-to-sales that is 6.8% above the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.49. Annualized volatility over the trailing 10 years is 36.32%. The trailing one-year price return is −2.77%. Across 10 years the annualized return works out at +13.85%.

Growth & Income

The record shows no dividend for MMSI.

2026 is still running; the price is +1.66% year to date. The strongest complete calendar year on file is 2020 at +77.80%; the weakest is 2019 at −44.06%. Of the 9 complete calendar years on file, 7 finished higher.

Peer Comparison

Merit Medical Systems, Inc. (MMSI) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Merit Medical Systems, Inc. MMSI $5.35B 36.6
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Merit Medical Systems, Inc. trades at a P/E of 36.6.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Visit website →